AMBER THERAPEUTICS HOLDINGS LIMITED
Research and experimental development on biotechnology
AMBER THERAPEUTICS HOLDINGS LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Unit 1 Tech Foundry 2 Curie Avenue Didcot OX11 0QQ England
Full company profile for AMBER THERAPEUTICS HOLDINGS LIMITED (13089338), an active life sciences and medical technology company based in Didcot, England. Incorporated 18 Dec 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2023–2023)
Cash in Bank
£2.53M
Net Assets
-£2.35M
Total Liabilities
£8.41M
Turnover
N/A
Employees
15
Debt Ratio
139%
Financial History
Revenue, profit, EBITDA and key financial figures
2023 31 Dec Year End | |
|---|---|
| P&L | |
| Revenue | |
| Gross Profit | |
| Operating Profit | |
| Net Profit | |
| EBITDA | |
| Assets | |
| Cash | |
| Total Assets | |
| Liabilities | |
| Total Liabilities | |
| Key Metrics | |
| Employees | |
Funding
Fundraising & Grants
Investors (6)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Jun 2024 | Series A |
| Investor 2 | Jun 2024 | Series A |
| Investor 3 | Jun 2024 | Series A |
See all 6 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Liliane Chamas | Director | British,canadian | United Kingdom | 18 Jun 2021 | Active |
| Yen-min Kevin Chu | Director | Canadian | United States | 23 May 2024 | Active |
See all 8 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Oxford Science Enterprises Holdings Ii Limited
Unknown
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
Oxford Science Enterprises Plc
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Aidan Harold Winston Crawley
Ceased 18 Jun 2021
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 24 Dec 2025 | Confirmation Statement | Confirmation statement made on 17 Dec 2025 with updates | |
| 23 Dec 2025 | Persons With Significant Control | Cessation of Oxford Science Enterprises Plc as a person with significant control on 28 May 2025 | |
| 23 Dec 2025 | Persons With Significant Control | Oxford Science Enterprises Holdings Ii Limited notified as a person with significant control | |
| 18 Dec 2025 | Officers | Appointment of Mr David Rogers Amerson as director | |
| 5 Sept 2025 | Accounts | Annual accounts made up to 31 Dec 2024 |
Confirmation statement made on 17 Dec 2025 with updates
Cessation of Oxford Science Enterprises Plc as a person with significant control on 28 May 2025
Oxford Science Enterprises Holdings Ii Limited notified as a person with significant control
Appointment of Mr David Rogers Amerson as director
Annual accounts made up to 31 Dec 2024
Recent Activity
Latest Activity
Confirmation statement made on 17 Dec 2025 with updates
5 months ago on 24 Dec 2025
Cessation of Oxford Science Enterprises Plc as a person with significant control on 28 May 2025
5 months ago on 23 Dec 2025
Oxford Science Enterprises Holdings Ii Limited notified as a person with significant control
5 months ago on 23 Dec 2025
Appointment of Mr David Rogers Amerson as director
5 months ago on 18 Dec 2025
Annual accounts made up to 31 Dec 2024
9 months ago on 5 Sept 2025